Clinical trials: Neurotmesis of Peripheral Nerve (Disorder)
Peripheral Nerve Injury
Safety and Efficacy Study of Neovasculgen (Pl-VEGF165) Gene Therapy in Patients With Peripheral Nerve Injury
The purpose of this study is to determine safety and efficacy of pl-vegf165 ("Neovasculgen") for regeneration of peripheral nerve.
- Trial name
- NCT02352649
- Testing
- Neovasculgen
- Volunteers
- 45 people
- Sponsor
- Artgen Biotech
Neurotmesis of Peripheral Nerve (Disorder)
Intraoperative ADSC Administration During Nerve Release
The goal of the investigator's observational, nonrandomized, open label study is to investigate the safety and efficacy of autologous adipose derived mesenchymal cells (ADSC) transplantation into the individuals with faiure in…
- Trial name
- NEUROASC (NCT04346680)
- Testing
- ADSC administration
- Volunteers
- 6 people
- Sponsor
- Mossakowski Medical Research Centre Polish Academy of Sciences